Employees Retirement System of Texas’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-72,964
Closed -$6.28M 322
2024
Q4
$6.28M Buy
72,964
+6,560
+10% +$709K 0.05% 150
2024
Q3
$7.91M Buy
66,404
+8,890
+15% +$1.19M 0.07% 137
2024
Q2
$8.21M Buy
57,514
+3,613
+7% +$479K 0.08% 129
2024
Q1
$6.92M Buy
+53,901
New +$6.42M 0.08% 138
2022
Q3
Sell
-2,906
Closed -$162K 580
2022
Q2
$162K Hold
2,906
﹤0.01% 696
2022
Q1
$161K Hold
2,906
﹤0.01% 736
2021
Q4
$163K Buy
+2,906
New +$157K ﹤0.01% 742
2020
Q1
Sell
-180,000
Closed -$5.21M 784
2019
Q4
$5.21M Hold
180,000
0.08% 293
2019
Q3
$4.65M Buy
+180,000
New +$4.55M 0.07% 316

Other funds holding NVO

Employees Retirement System of Texas's NVO Position: Q1 2025 in Review

Employees Retirement System of Texas sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 72,964 shares — an estimated $6.28M sold.

Employees Retirement System of Texas first reported a position in NVO in Q3 2019 and held it in 9 quarters. The position peaked at $8.21M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Employees Retirement System of Texas reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 72,964 Novo Nordisk shares in Q1 2025, an estimated $6.28M.
  • Employees Retirement System of Texas first reported a position in Novo Nordisk in Q3 2019 and held it in 9 quarters.
  • Employees Retirement System of Texas's Novo Nordisk position peaked at $8.21M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Employees Retirement System of Texas's 13F filing for Q1 2025, filed 13 May 2025.